Logo_MBI_web.png
Marrone Bio’s Inventory Line of Credit Increased to Support Sales and Manufacturing Growth
06. Januar 2022 09:01 ET | Marrone Bio Innovations
RALEIGH, N.C., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) has expanded its existing inventory line of credit to support the company’s expectations for growth in...
Logo_MBI_web.png
Marrone Bio Relocates Corporate Headquarters to Raleigh, North Carolina
06. Januar 2022 09:00 ET | Marrone Bio Innovations
RALEIGH, N.C., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, today announced it has...
Logo_MBI_web.png
Marrone Bio Warrant Holders Exercise Final Tranche, Eliminating Warrant Overhang
16. Dezember 2021 16:30 ET | Marrone Bio Innovations
DAVIS, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) -- During November and December 2021, certain warrant holders in Marrone Bio Innovations, Inc. (NASDAQ: MBII) completed the exercise of the fifth and...
Logo_MBI_web.png
Marrone Bio Optimizes Bioherbicide with New Bacteria Strains, Accelerates Product Development to Enter $27 Billion Herbicide Market¹
16. Dezember 2021 08:00 ET | Marrone Bio Innovations
DAVIS, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), has acquired exclusive rights to high-performing strains of Streptomyces acidiscabies, allowing for the...
Logo_MBI_web.png
Marrone Bio’s Next-Generation Product for Environmentally Sustainable Pest Control Demonstrates Substantial Yield Gains in 2021 Field Trials
08. Dezember 2021 08:00 ET | Marrone Bio Innovations
DAVIS, Calif., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Field trials in 2021 for Marrone Bio Innovations’ (NASDAQ: MBII) next-generation product for environmentally sustainable control of yield-robbing...
Logo_MBI_web.png
Marrone Bio Achieves Excellent Climate Impact Score for Venerate® XC Bioinsecticide
17. November 2021 17:00 ET | Marrone Bio Innovations
DAVIS, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions published today...
Logo_MBI_web.png
Marrone Bio Innovations, Inc. Reports Third-Quarter 2021 Financial Results
10. November 2021 16:01 ET | Marrone Bio Innovations
DAVIS, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its...
Logo_MBI_web.png
Marrone Bio Innovations Receives Nasdaq Notice Regarding Failure to Satisfy a Continued Listing Rule
08. November 2021 07:00 ET | Marrone Bio Innovations
DAVIS, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (Nasdaq: MBII) today announced that it has received a letter from the Listing Qualifications Department of the Nasdaq...
Logo_MBI_web.png
Marrone Bio Submits Regulatory Packages for Nematicides/Insecticides in United States and Brazil
01. November 2021 07:00 ET | Marrone Bio Innovations
DAVIS, Calif., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, has submitted the...
Logo_MBI_web.png
Marrone Bio Innovations to Report Third Quarter 2021 Results on Wednesday, November 10 at 4:30 p.m. Eastern Time
27. Oktober 2021 07:00 ET | Marrone Bio Innovations
DAVIS, Calif., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions...